Cancer Genetics Inc (NASDAQ:CGIX)

1.80
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.30
-2.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues7.2M7.0M6.6M8.0M
 
 
 
 
 
Cost of Goods Sold3.7M3.6M3.5M4.1M
 
 
 
 
 
Depreciation And Amortization613.0K617.0K530.0K523.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.0M2.8M2.6M3.4M
 
 
 
 
 
General Expenses6.4M5.5M5.7M6.5M
 
 
 
 
 
Research And Development1.1M1.1M982.0K979.0K
 
 
 
 
 
Total Operating Expenses10.7M9.8M9.7M11.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-2.8M-3.1M-3.0M
 
 
 
 
 
Extraordinary Credit829.0K0.00590.0K2.9M
 
 
 
 
Extraordinary Charge0.00-7.5M0.00-150.0K
 
 
 
Pre-Tax Equity Earnings-28.0K-12.0K-7.0K-2.0K
 
 
 
 
 
Interest Expense On Debt110.0K194.0K253.0K350.0K
 
 
 
 
 
Other Expenses0.00-46.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-10.6M-2.8M-633.0K
 
 
 
 
 
Income Taxes0.00-970.0K0.000.00
 
 
Net Income-2.8M-9.6M-2.8M-633.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.8M18.9M19.7M21.6M
 
 
 
 
 
Shares To Calculate EPS Diluted18.8M18.9M20.7M22.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.51-$0.16-$0.15
 
 
 
 
 
EPS Diluted-$0.15-$0.51-$0.16-$0.15